Neomta
Device Restorative Dentistry
General payments
$525,907
Research payments
$3,350
Through program year 2025, $525,907 in general payments and $3,350 in research payments were reported against Neomta (Restorative Dentistry).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $5,035 | 3 |
| 2023 | General | $99,478 | 56 |
| 2022 | General | $220,304 | 358 |
| 2022 | Research | $3,350 | 3 |
| 2021 | General | $118,733 | 176 |
| 2020 | General | $53,911 | 150 |
| 2019 | General | $28,447 | 59 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
802 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.